The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Fredun Pharmaceuticals Ltd

Fredun Pharmaceuticals Ltd

BSE 539730 · NSE FREDUN · ISIN INE194R01017 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹1,477.05

-0.88%

BSE close, 28 August 2026

Market cap

₹2,442.76 cr

1.7 cr shares · Micro cap

Free float

₹1,061.75 cr

as published

P/E · P/B

55.0× · 18.67×

EPS ₹26.87 · BV ₹79.11

FY25-26 rev / PAT

633.33 / 33.21

₹ cr, as filed

Filings, window

24

11 selected · 46%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹376.29 52-WK HIGH ₹1,600.00 ₹1,477.05 90% of range
Against 52-week high-7.7%
Against 52-week low+292.5%
Day change-0.88%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹26.87
Price / earnings54.97×
Price / book18.67×
Book value — derived, price ÷ P/B₹79.11
Return on equity33.96%
Operating margin14.39%
Net margin5.78%

Consistency check

P/B ÷ P/E, which must equal ROE
33.96%
ROE as published
33.96%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 227.76 13.17 23.89 14.39% 5.78%
Mar-26 · Q 210.41 11.07 20.22 13.84% 5.26%
FY25-26 633.33 33.21 68.01 14.97% 5.24%

Quarter on quarter

Revenue, quarter on quarter
+8.2%
Net profit, quarter on quarter
+19.0%
Operating margin, quarter on quarter
+55 bps

Disclosure profile 24 filings in the window

0 median 17.0 p75 · 25 sector max 52 24 74th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Press Release8
Board Outcome1
Concall Transcript1
Results1
Selected sub-total11
Procedural
Allotment3
General3
Analyst / Investor Meet1
Board Meeting1
Monitoring Agency1
Newspaper Publication1
Other Update1
Outcome1
Trading Window1
Procedural sub-total13
Total24

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

24 filings · 11 selected · busiest 2026-08-06 and 2026-09-22

Filing rhythm · the twelve most recent

2026-09-082026-10-08

SelectedProcedural

Filings

24 in the window · 15 earlier on record

  1. 8 October 2026 ·

    Press Release

    Press Release / Media Release

    Press Release Issued by Fredun Pharmaceuticals Limited dated 08 October, 2026.

    Company Update / Press Release / Media Release View filing →

  2. 5 October 2026 ·

    Allotment

    Allotment

    Revised Allotment of Rs. 182400 Equity Shares.

    Company Update / Allotment of Equity Shares View filing →

  3. 5 October 2026 ·

    General

    Revised Outcome Of Board Meeting Dated 03Rd October, 2026.

    Revised Outcome of Board Meeting Dated 03rd October, 2026.

    Company Update / General View filing →

  4. 28 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of Trading Window Closure

    Insider Trading / SAST / Closure of Trading Window View filing →

  5. 22 September 2026 ·

    Allotment

    Allotment

    Revised Allotment of Equity Shares pursuant to conversion of warrants.

    Company Update / Allotment of Equity Shares View filing →

  6. 22 September 2026 ·

    General

    Revised Outcome Of Board Meeting Dated 16Th September, 2026

    Revised Outcome of Board Meeting Dated 16th September, 2026

    Company Update / General View filing →

  7. 22 September 2026 ·

    Press Release

    Press Release / Media Release

    Press Release by FPL dated- 22-09-2026

    Company Update / Press Release / Media Release View filing →

  8. 16 September 2026 ·

    Allotment

    Allotment

    Allotment of 271200 Equity Shares upon Conversion of Warrants.

    Company Update / Allotment of Equity Shares View filing →

  9. 16 September 2026 ·

    Outcome

    Board Meeting Outcome for Allotment Of 2,71,200 Equity Shares To Non-Promoter Upon Conversion Of Warrants Into Equity Shares

    Allotment of 2,71,200 Equity Shares to Non-Promoter upon conversion of Warrants into Equity Shares.

    Others / Outcome without intimation View filing →

  10. 15 September 2026 ·

    Press Release

    Press Release / Media Release (Revised)

    Press Release

    Company Update / Press Release / Media Release (Revised) View filing →

  11. 15 September 2026 ·

    Press Release

    Press Release / Media Release

    PRESS RELEASE

    Company Update / Press Release / Media Release View filing →

  12. 8 September 2026 ·

    Press Release

    Press Release / Media Release

    Press Release issued by Fredun Pharmaceuticals Limited

    Company Update / Press Release / Media Release View filing →

  13. 4 September 2026 ·

    Press Release

    Press Release / Media Release

    Press Release issued by Fredun Pharmaceuticals Limited dated 04.09.2026

    Company Update / Press Release / Media Release View filing →

  14. 17 August 2026 ·

    General

    Intimation Regarding Permission To Trade And Admission Of Equity Shares To Dealings On The National Stock Exchange Of India Limited.

    Intimation regarding permission to trade and admission of Equity Shares to dealing on the National Stock Exchange of India

    Company Update / General View filing →

  15. 17 August 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Transcript of the Earnings Conference call held on 13th August, 2026 for Q1 FY27.

    Company Update / Earnings Call Transcript View filing →

  16. 14 August 2026 ·

    Other Update

    539730 - Statement Of Deviation Or Variation For The Quarter Ended June 30, 2026

    Statement of Deviation or Variation For the Quarter Ended June 30, 2026.

    Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →

  17. 14 August 2026 ·

    Monitoring Agency

    Monitoring Agency Report

    Monitoring Agency Report dated 14.08.2026

    Company Update / Monitoring Agency Report View filing →

  18. 13 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Audio Recording Q1 FY27 'Earnings Conference Call' of Fredun Pharmaceuticals Limited.

    Company Update / Analyst / Investor Meet View filing →

  19. 6 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement of the Un-Audited Financial Results for Quarter ended 30th June, 2026

    Company Update / Newspaper Publication View filing →

  20. 6 August 2026 ·

    Press Release

    Press Release / Media Release

    Newspaper Advertisement of the Un-Audited Financial Results for Quarter ended 30th June, 2026

    Company Update / Press Release / Media Release View filing →

  21. 6 August 2026 ·

    Press Release

    Press Release / Media Release

    Press Release issued by Fredun Pharmaceuticals Limited

    Company Update / Press Release / Media Release View filing →

  22. 5 August 2026 ·

    Results

    Outcome Of The Board Meeting

    Outcome of the Board Meeting

    Result / Financial Results View filing →

  23. 5 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting

    In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the quarter ended ....

    Board Meeting / Outcome of Board Meeting View filing →

  24. 30 July 2026 ·

    Board Meeting

    Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Wednesday, 05Th August, 2026.

    Fredun Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Notice is hereby given ....

    Board Meeting / Board Meeting View filing →

RSS feed for Fredun Pharmaceuticals Ltd · the 50 most recent filings